IP Library › Granted Patent US 11,638,721
Granted Patent B2
US 11,638,721 · App. 16/210,790 · Granted May 2, 2023

Antibacterial composition and its use in treating bacterial infections

Inventors: Peter Y. Novak (Sunny Isles Beach, FL); Maxim V. Temnikov (Miami, FL); Oleksandr Balakin (Dnepropetrovsk, UA)
Assignee: Vector Vitale IP LLC
A61K33/30A61K8/19A61K9/0053A61K9/06A61K33/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,638,721
App. No.
16/210,790
Granted
May 2, 2023
Kind
B2
Abstract

An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1 H, 12 C, 16 O, 14 N, 39 K, 24 Mg, 64 Zn, 85 Rb, 28 Si, 54 Fe, 92 Mo, 74 Se, 58 Ni, 70 Ge, 52 Cr, 63 Cu, 50 V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.

Claims (6)

1. A method of treating a condition that is caused by or characterized by a bacterial infection or excessive bacterial growth in a person or veterinary mammal that exhibits such a condition, wherein the method comprises administering an antibacterial composition comprising a bacteriostatic or bactericidal effective amount of at least one light isotope-enriched element selected from the group consisting of Mg that is at least 95% 24 Mg, Rb that is at least 90% 85 Rb, Mo that is at least 80% 92 Mo, Se that is at least 50% 74 Se, Ge that is at least 80% 70 Ge, Cr that is at least 90% 52 Cr, Fe that is at least 80% 54 Fe e , Ni that is at least 90% 58 Ni, Cu that is at least 90% 63 Cu, and V that is at least 85% 50 V, wherein the light-isotope-enriched element is present in elemental form or in the form of a pharmaceutically acceptable salt, compound or complex thereof, to said person or said veterinary mammal.

2. The method of claim 1 , wherein the condition is acne.

3. The method of claim 1 , wherein the condition is sepsis.

4. The method of claim 1 , wherein the condition is a bacterial infection.

5. The method of claim 1 , wherein the composition comprises one or more of: between 15 mg and 8.4 grams of Mg that is at least 95% 24 Mg, between 500 μg and 40 mg of Rb that is at least 90% 85 Rb, between 750 μg and 380 mg of Mo that is at least 80% 92 Mo, between 7.5 μg and 1100 μg of Se that is at least 50% 74 Se, between 500 μg and 20 mg of Ge that is at least 80% 70 Ge, between 0.1 ng and 700 μg of Cr that is at least 90% 52 Cr, and between 20 μg and 800 μg of V that is at least 85% 50 V, present in elemental form or in the form of a pharmaceutically acceptable salt, compound or complex thereof.

6. The method of claim 5 , wherein the at least one light isotope-enriched element is present in the form of a pharmaceutically acceptable salt, compound or complex thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2021
From: BALAKIN, OLEKSANDR
To: NOVAK, PETER Y.; TEMNIKOV, MAXIM V.
Reel/Frame 055908/0791 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2020
From: NOVAK, PETER Y.; TEMNIKOV, MAXIM V.
To: VECTOR VITALE IP LLC
Reel/Frame 051579/0499 →
Continuity (2)
Division 15486026 · Apr 12, 2017
Related Publication 20190105345A1 · Apr 11, 2019
Cited By (1)
US 12,734,240